Media type: E-Article Title: Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia Contributor: Kobayashi, Ryoji; Tawa, Akio; Hanada, Ryoji; Horibe, Keizo; Tsuchida, Masahiro; Tsukimoto, Ichiro imprint: Wiley, 2007 Published in: Pediatric Blood & Cancer Language: English DOI: 10.1002/pbc.20824 ISSN: 1545-5017; 1545-5009 Origination: Footnote: Description: <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Extramedullary infiltration (EMI) is an occasional clinical symptom in childhood acute myelogenous leukemia (AML), but there is considerable controversy regarding the prognostic significance of EMI in AML.</jats:p></jats:sec><jats:sec><jats:title>Procedure</jats:title><jats:p>We evaluated the frequency and prognostic significance of EMI at diagnosis of AML in children.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of 240 cases of de novo AML excluding children with Down syndrome and acute promyelocytic leukemia, 56 (23.3%) showed EMI at diagnosis. Patients with EMI had a higher initial WBC count and a higher proportion of M4/M5 morphological variants. The complete remission rate following induction chemotherapy was lower in patients with EMI. However, the overall survival and event‐free survival did not differ between patients with and without EMI. A detailed analysis showed that patients with EMI with a WBC count at diagnosis of over 100 × 10<jats:sup>9</jats:sup>/L or infiltration into the central nervous system are likely to have a poor prognosis.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>CNS leukemia and EMI together with a WBC count of >100 × 10<jats:sup>9</jats:sup>/L at diagnosis of AML are high risk factors for relapse, and alternative treatment approaches for patients with these characteristics should be explored. Pediatr Blood Cancer © 2006 Wiley‐Liss, Inc.</jats:p></jats:sec>